agreed, their IR/communication strategy and execution is lacking since they really have no Business/Exec leadership and the person leading IR is doing this by default because no one else can communicate effectively (verbally). So, until they have some real news like a partnership or acquisition, or later phase news, or until they get some respected leadership with a track record of business success, this is what we get.
They are still in control until/unless there's more buying volume to force them to cover. Maybe some follow on partner news, or news about all options being on the table would do the trick. The PR was a little too vague IMO.
EXAS might be another winner that he turns into a loser by holding too long. Wishing him nothing but the worst. But, I also let a winner turn into a loser, so I guess I'm in the same boat...
if you treat them reasonably well, they respond. I'm hard on them, but I try to be at least somewhat respectful and they do respond to my calls and emails most of the time.
1) sector has recovered some 2) there a possibility of some long over-due news (some day)...
Shorts know Craig is out today, so either no news, or bad news, but probably no news today. Execs away, shorts play. For traders it's an opportunity to buy the dip assuming no bad news...
Let's go ARNA, shareholders want info, results, progress, ROI not talk and empty promises.
royalty is a % of sales, not profits and I recall they get a royalty % of the total combo or triplet sale, not just the amount for the ACH drug, which is huge, if any. Not costs and teens sales is, or would be a great deal for ACHN. Still a long way to go, but more will known soon.
I think the whole sector has started to recover + the failure of the Pfizer deal seems to have energized the smaller bio-pharmas, maybe more smaller deals now and fewer large deals, which is fine with me!
since it's only phase 1 and healthy volunteers, I'm not sure how astounding it could be and I can't understand why it's this late. Maybe they need to hire more project managers to recruit sites and patients, or better consultants in this area because they are not getting the job done, just like the so called marketing research that was done for Belviq. Any serious MR company that properly interviewed KOL's and physicians should have been able to predict this slow launch and lower market potential, at least prior to wide insurance coverage, which requires a Health Econ/Outcomes study...and as mentioned above, x-US market approval/acceptance has been unacceptable.
it's already slipped from by the end of 2015 to 1Q or "around the end of March" so my point is they have NO clue, they are not accurate, or they are not moving with enough urgency!!!
Depends on what the definition of the word "around" is. No new CEO, late on the already pushed back data release (for a phase I study), pushed back all other deadlines, either this company can't forecast, can't execute, or is busy doing a deal to be sold. Who knows since they also can't communicate clearly and accurately!
It's funny, I harassed the BOD for about 2 years trying to get them to fire Junius the loser, but they did nothing. I finally sold (too low out of frustration). They need to kick the IR person out along with him and the Chairman too. They are all terrible!
you should take a look in the mirror and ask, is this what God made me to do, spend all day trying to tear down people and stocks? I don't think so. Repent and change.